The meningitis diagnostic testing market was valued at USD 149.43 Million in 2025, driven by the advancements in molecular diagnostics across the globe. The market is anticipated to grow at a CAGR of 3.40% during the forecast period of 2026-2035, with the values likely to reach USD 208.76 Million by 2035.
Base Year
Historical Period
Forecast Period
In December 2024, Delve Bio launched Delve Detect, a metagenomic CSF test detecting over 68,000 pathogens with a 48-hour turnaround. Such innovative diagnostics are expected to accelerate growth in the meningitis diagnostic testing market.
One of the major trends in the market include the growing use of syndromic panels. For instance, in November 2024, QIAGEN received FDA clearance for its QIAstat-Dx Meningitis/Encephalitis panel, enabling one-hour, real-time PCR-based results for rapid CNS infection diagnosis.
North America is expected to lead the market, driven by the early adoption of rapid meningitis diagnostic tools, robust healthcare infrastructure, high awareness of meningitis symptoms, and strong investment in infectious disease research.
Compound Annual Growth Rate
3.4%
Value in USD Million
2026-2035
*this image is indicative*
Meningitis diagnostic testing detects infections causing inflammation of the meninges through cerebrospinal fluid, blood analysis, or imaging. The market is driven by rising disease prevalence, demand for rapid results, and advancements in diagnostic technologies. Molecular diagnostics and polymerase chain reaction methods are increasingly adopted for their accuracy. Key companies focus on innovation and product development. Improved healthcare access and ongoing research are expected to support market growth.
Accelerated Molecular Testing Drives Growth in Market
Rapid advancements in molecular diagnostics are propelling growth in the meningitis diagnostic testing market. In July 2022, Abacus Diagnostica introduced the CE-marked GenomEra® assay kit, delivering accurate viral meningitis results in just 70 minutes. This innovation reduces diagnostic delays and curbs unnecessary antibiotic use, significantly boosting market adoption and meeting the growing demand for efficient testing solutions.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
Market Breakup by End User
Market Breakup by Region
PCR Test Segment Poised to Hold a Significant Market Value for Segmentation by Test Type
Based on the test type, the market is divided into latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others. Among these, PCR assays are expected to hold a significant share of the market due to their high accuracy, rapid results, and widespread use in diagnosing infectious diseases and genetic conditions. Their ability to detect minute quantities of genetic material makes them a preferred choice.
The regions included in the report are North America, Europe, Asia-Pacific, Latin America, and MEA. North America is expected to witness a substantial share of the meningitis diagnostic testing market. In the United States, the incidence of meningococcal disease has increased sharply since 2021, surpassing pre-pandemic levels. In 2023, 438 confirmed and probable cases were reported, emphasizing the need for improved diagnostic testing and prevention strategies.
The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Becton, Dickinson and Company, established in 1897 and headquartered in New Jersey, United States, is a leading player in the global meningitis diagnostic testing market. The company offers BD Directigen immunoassay test kits, which provide rapid and qualitative detection of meningitis-related antigens in cerebrospinal fluid, serum, or urine, reinforcing its commitment to infectious disease diagnostics.
BioMérieux, founded in 1963 is a global leader in in-vitro diagnostics. The company plays a key role in the meningitis diagnostic testing market with its Biofire filmarray Meningitis/Encephalitis (ME) panel. This panel rapidly identifies 14 common central nervous system pathogens from cerebrospinal fluid in about one hour, aiding timely and accurate diagnosis.
Bio-Rad Laboratories was established in 1952. The company is actively involved in the market through its Pastorex Meningitis assay. This rapid latex agglutination test enables accurate detection of key bacterial pathogens in cerebrospinal fluid and blood cultures, supporting early diagnosis and effective outbreak management of bacterial meningitis.
Certest Biotec is a biotechnology company specializing in molecular diagnostics. In the meningitis diagnostic testing market, it offers the Viasure Viral meningitis panel real time PCR detection kit, designed for the qualitative detection of viral DNA/RNA associated with meningitis. Although intended for research use only, the product reflects Certest’s active role in advancing meningitis-related molecular testing.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Abbott Laboratories, ELITechGroup, F. Hoffmann-La Roche, Seegene Inc., Thermo Fisher Scientific Inc., and Siemens Healthineers.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share